<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="151292">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01824589</url>
  </required_header>
  <id_info>
    <org_study_id>ACSI W81XWH-11-1-0542</org_study_id>
    <secondary_id>W81XWH-11-1-0542</secondary_id>
    <nct_id>NCT01824589</nct_id>
  </id_info>
  <brief_title>Effect of Intrathoracic Pressure Regulation on Traumatic Brain Injury</brief_title>
  <official_title>Effects of Intrathoracic Pressure Regulation Therapy in Patients With Elevated Intracranial Pressure Due to Brain Injury or Intracranial Pathology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Advanced Circulatory Systems</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>U.S. Army Medical Research and Materiel Command</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>Advanced Circulatory Systems</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to demonstrate proof of clinical concept that application of
      the Intrathoracic Pressure Regulator (ITPR) will result in an increase in Cerebral Perfusion
      Pressure (CPP) and a decrease in Intracranial Perfusion Pressure (ICP) in patients with head
      injury and elevated ICP, and to determine the optimal ventilation tidal volume (TV).
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>August 2012</start_date>
  <primary_completion_date type="Anticipated">August 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Intracranial Pressure (ICP)</measure>
    <time_frame>15 minutes after device is activated</time_frame>
    <safety_issue>No</safety_issue>
    <description>Change in ICP from baseline will be compared with the ICP during 15 minutes of ITPR use.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cerebral Perfusion Pressure (CPP)</measure>
    <time_frame>15 minutes after device activation</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measurement of the mean and max CPP during ITPR use and time to maximum increase in CPP.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung compliance</measure>
    <time_frame>baseline and up to 20 minutes after device removal</time_frame>
    <safety_issue>No</safety_issue>
    <description>Change in lung compliance following each ITPR treatment and 20 minutes following removal of the ITPR compared to baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial blood gases</measure>
    <time_frame>15 minutes after device activation</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Arterial blood gases will be collected and compared to baseline values.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Head Injury</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>tidal volume setting of 6ml/kg with the -7cm H2O ITPR as first device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>tidal volume setting of 8ml/kg with the -7cm H2O ITPR as first device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>tidal volume setting of 6ml/kg with the -12cm H2O ITPR as first device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>tidal volume setting of 8ml/kg with the -12cm H2O ITPR as first device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>-7 cm H2O ITPR</intervention_name>
    <description>Single use disposable non-invasive device that is connected to a vacuum source and a means to deliver a positive pressure breath and generates negative3 pressure during the expiratory phase, thus creating subatmospheric intrathoracic pressure of -7 cmH2O between periods of positive pressure ventilations.</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
    <other_name>Intrathoracic Pressure Regulator, CirQlator</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>-12cm H2O ITPR</intervention_name>
    <description>Single use disposable non-invasive device that is connected to a vacuum source and a means to deliver a positive pressure breath and generates negative3 pressure during the expiratory phase, thus creating subatmospheric intrathoracic pressure of -12 cmH2O between periods of positive pressure ventilations.</description>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_label>Group D</arm_group_label>
    <other_name>Intrathoracic Pressure Regulatory, CirQlator</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ≥15 years of age

          -  intubated and mechanically ventilated on a volume controlled mode

          -  head injury or other intracranial pathology with ICP of ≥15 mmHg

          -  arterial line in place

          -  SpO2 ≥95%

          -  MAP &gt;60

          -  in ICU or about to undergo neurosurgery with planned placement of an ICP monitor

          -  inclusion presents no significant delays to planned emergent neurosurgery

          -  prior written informed consent

        Exclusion Criteria:

          -  cardiac or pulmonary injury impacting intrathoracic pressure

          -  confirmed pneumothorax or hemothorax

          -  PaO2/FiO2 &lt;300

          -  serious neck injury resulting in neck swelling with jugular venous compression

          -  evidence of ongoing uncontrolled bleeding

          -  respiratory disease such as COPD, interstitial lung disease, or other parenchymal or
             pulmonary vascular disease

          -  congestive heart failure
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 2, 2013</lastchanged_date>
  <firstreceived_date>March 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>traumatic brain injury</keyword>
  <keyword>TBI</keyword>
  <keyword>ITPR</keyword>
  <keyword>intrathoracic pressure regulator</keyword>
  <keyword>hepatic encephalopathy</keyword>
  <keyword>pseudotumorcerebri</keyword>
  <keyword>obstructive hydrocephalus</keyword>
  <keyword>intracranial hemorrhage</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Craniocerebral Trauma</mesh_term>
    <mesh_term>Intracranial Hypertension</mesh_term>
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
